SCR-LIP-000496 · Claim · machine-readable JSON →
Among 440 lower-extremity lymphedema patients, 52 had lipedema with secondary lymphedema (lipolymphedema), of whom 88.5% showed permanent foot/dorsum edema consistent with ISL stage II-III secondary lymphedema and 38.5% had a history of cellulitis.
This single-paper claim was consolidated into general propositions (R-CLM-19); its evidence now sits under:
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- low (GRADE)
- Evidence
- 1 source(s)
- Answers
- 0 question(s)
- Dates
- 2026-11-17 → 2026-11-17
Structured evidence, machine-compiled — not a verdict.
Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-11-17
Evidence over time
Evidence (1)
- The clinical characteristics of lower extremity lymphedema in 440 patients (2020) ✓ verified — consistent · cross sectional · 2020 · reading confidence: high
Retrospective chart review documents that lipedema patients progressed to secondary lymphedema (stage II-III) with permanent foot edema and cellulitis, supporting progression to lymphedema; functional disability is not directly measured but
Context (PECO)
Answers these questions
- Not yet linked to a question.
Gaps & caveats
Auto-ingested single source; not yet human-reviewed.
Change log
- 2026-11-17 — created · auto-ingested for SQ-LIP-000017
- 2026-11-20 — consolidated · SQ-LIP-000017: evidence moved to SCR-LIP-000672